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need to reflect the 
actual needs of the 
proposed project and 
should be limited to no 
more than $2.5 million 
direct costs per year. 
Biomarkers of Alzheimer’s 
Disease in Down Syndrome 








are limited to no more 
than $750,000 direct 
costs per year.  
Interdisciplinary Research to 
Understand the Vascular 
Contributions to Alzheimer's 
Disease 





3 癫痫 Application budgets 
may not exceed $3 
million direct costs per 
year.  
Centers Without Walls for 
Collaborative Research in the 
Epilepsies: Developing 
Disease Modifying or 
Prevention Therapies 








According to statutory 
guidelines, total 
funding support (direct 
costs, indirect costs, 
fee) normally may not 
Tools for Assessment and 
Improvement of Neurologic 
Outcomes in Perinatal 
Medicine  











excee $150,000 for 
Phase I awards.  
year for Phase I 





According to statutory 
guidelines, total 
funding support (direct 
costs, indirect costs, 
fee) normally may not 
exceed $150,000 for 
Phase I awards.  
Tools for Assessment and 
Improvement of Neurologic 
Outcomes in Perinatal 
Medicine 




may not exceed 1 






6 人脑连接组 The application budget 
is limited to $750,000 
total costs.  
Limited Competition for a 
Connectome Coordination 
Facility  




7 复杂脑疾病 Direct costs are limited 
to $275,000 over an 
R21 two-year period, 
with no more than 
$200,000 in direct 
costs allowed in any 
single year 
Molecular and Cellular 
Substrates of Complex Brain 
Disorders - 





8 复杂脑疾病 未限定 Molecular and Cellular 
Substrates of Complex Brain 
Disorders  






9 精神卫生 Application budgets 
may not exceed 
$200,000 in direct 
costs annually. 
NIMH Short Courses for 
Mental Health-Related 
Research Education  





10 精神卫生 Application budgets 
may not exceed 
$200,000 in direct 
costs annually.  
NIMH Mentoring Networks 
for Mental Health Research 
Education  





11 衰老 Application budgets 
are limited to no more 
than $600,000 per year 
in Direct Costs. 
Nathan Shock Centers of 
Excellence in Basic Biology of 
Aging 







未限定 Blueprint Neurotherapeutics 
Network (BPN): Small 
Molecule Drug Discovery and 
Development for Disorders of 
the Nervous System 
July 22, 2014 Applicants may 
seek up to one year 




of the UH2 and 
UH3 award cannot 









rarely exceed up to 
Blueprint Neurotherapeutics 
Network (BPN): Small 
July 22, 2014 Durations up to 1 




$400,000 total cost for 
Phase I and up to 
$4,000,000 total cost 
for the Phase II.  
Molecule Drug Discovery and 
Development for Disorders of 
the Nervous System  
and up to 3 years 
for Phase II may 




14 人脑连接组 未限定 Connectomes Related to 
Human Disease 
July 14, 2014 The maximum 










are limited to $900,000 
total costs.  
Neuroscience Information 
Framework 
July 14, 2014 2 years http://grants.nih.gov/
grants/guide/rfa-
files/RFA-DA-15-
009.html 
 
 
